6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Outcome measures for technique survival reported in peritoneal dialysis: A systematic review

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Peritoneal dialysis (PD) technique survival is an important outcome for patients, caregivers and health professionals, however, the definition and measures used for technique survival vary. We aimed to assess the scope and consistency of definitions and measures used for technique survival in studies of patients receiving PD.

          Method:

          MEDLINE, EMBASE and CENTRAL databases were searched for randomised controlled studies (RCTs) conducted in patients receiving PD reporting technique survival as an outcome between database inception and December 2019. The definition and measures used were extracted and independently assessed by two reviewers.

          Results:

          We included 25 RCTs with a total of 3645 participants (41–371 per trial) and follow up ranging from 6 weeks to 4 years. Terminology used included ‘technique survival’ (10 studies), ‘transfer to haemodialysis (HD)’ (8 studies) and ‘technique failure’ (7 studies) with 17 different definitions. In seven studies, it was unclear whether the definition included transfer to HD, death or transplantation and eight studies reported ‘transfer to HD’ without further definition regarding duration or other events. Of those remaining, five studies included death in their definition of a technique event, whereas death was censored in the other five. The duration of HD necessary to qualify as an event was reported in only four (16%) studies. Of the 14 studies reporting causes of an event, all used a different list of causes.

          Conclusion:

          There is substantial heterogeneity in how PD technique survival is defined and measured, likely contributing to considerable variability in reported rates. Standardised measures for reporting technique survival in PD studies are required to improve comparability.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

          Systematic reviews should build on a protocol that describes the rationale, hypothesis, and planned methods of the review; few reviews report whether a protocol exists. Detailed, well-described protocols can facilitate the understanding and appraisal of the review methods, as well as the detection of modifications to methods and selective reporting in completed reviews. We describe the development of a reporting guideline, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015). PRISMA-P consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review. Funders and those commissioning reviews might consider mandating the use of the checklist to facilitate the submission of relevant protocol information in funding applications. Similarly, peer reviewers and editors can use the guidance to gauge the completeness and transparency of a systematic review protocol submitted for publication in a journal or other medium.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            What really happens to people on long-term peritoneal dialysis?

            Several risk factors for patients treated with peritoneal dialysis (PD) have now been identified. These include age, comorbid disease, nutritional status, loss of residual renal function (RRF) and high peritoneal solute transport. This is not the same, however, as knowing what actually happens to these patients, particularly in the long-term. The purpose of this review was to give as complete a description as is currently possible of the long-term PD patient. The literature was surveyed for publications that provide longitudinal cohort data of either selected or unselected patient groups. Detailed data from the Stoke PD Study is presented in the context of these studies. Three principle aspects of what really happens to patients were considered: (1) death, both cause and mode of death; (2) technique failure, with reference to peritoneal function and how the cause of technique failure related to patient survival; and (3) evolution of clinically relevant parameters of patients on PD, such as nutrition and peritoneal function. Sudden death and debilitation were the predominant modes of death, with sepsis playing a contributory role. Debilitation was important regardless of co-existent comorbid disease, and time to death was not influenced by the mode of death. Predominant causes for technique failure remain peritonitis and ultrafiltration, the latter becoming more important with time on treatment. Technical failure is associated with poorer survival, particularly when due to multiple peritonitis or failure to cope with treatment. Cox regression demonstrated that whereas low albumin, loss of RRF and high solute transport predicted patient death, only high solute transport predicted technique failure. Longitudinal changes over the first five years of treatment included loss of RRF, increasing solute transport and following an initial improvement in nutritional state, a decline after two years. Patients surviving long-term PD (at least five years, N = 25) were characterized by prolonged RRF, maintained nutrition and lower solute transport in the medium term. Several studies of long-term PD in the literature now complement each other in providing a picture of what really happens to PD patients. The links between loss of solute clearance and poor peritoneal ultrafiltration combining to exacerbate sudden or debilitated death and technique failure are emerging. For PD to be successful as a long-term therapy, strategies that maintain nutrition and preserve peritoneal membrane function must be developed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.

              Although previous studies suggest similar patient survival for peritoneal dialysis (PD) and haemodialysis (HD), PD use has decreased worldwide. We aimed to study trends in the choice of first dialysis modality and relate these to variation in patient and technique survival and kidney transplant rates in Europe over the last 20 years.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
                Perit Dial Int
                SAGE Publications
                0896-8608
                1718-4304
                May 2022
                April 21 2021
                May 2022
                : 42
                : 3
                : 279-287
                Affiliations
                [1 ]School of Medicine, Keele University, Newcastle, UK
                [2 ]Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia
                [3 ]Australasian Kidney Studies Network, The University of Queensland, Brisbane, Australia
                [4 ]Translational Research Institute, Brisbane, Australia
                [5 ]Department of Renal Medicine, Auckland City Hospital, Auckland, New Zealand
                [6 ]Polycystic Kidney Disease International, Geneva, Switzerland
                [7 ]Polycystic Kidney Disease Charity, London, UK
                [8 ]Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
                [9 ]Department of Medicine, Western University, London, Ontario, Canada
                [10 ]Botucatu School of Medicine, University of Sao Paulo State—UNESP, Brazil
                [11 ]Clinical Innovation and Business Unit, South Western Sydney Local Health District, Sydney, Australia
                [12 ]Faculty of Nursing, University of Sydney, Sydney, Australia
                [13 ]UNSW Faculty of Medicine, University of New South Wales, Sydney, Australia
                [14 ]School of Health Science, University of Tasmania, Hobart, Australia
                [15 ]Maisonneuve-Rosemont Research Centre and Hospital, Montreal, Canada
                [16 ]The Kidney and Transplant Practice, Mount Elizabeth Novena Hospital, Singapore
                [17 ]Medical School, University of Western Australia, Crawley, Australia
                [18 ]Sydney School of Public Health, University of Sydney and Centre for Kidney Research, The Children’s Hospital at Westmead, Sydney, Australia
                [19 ]Division of Nephrology, St Michael’s Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael’s Hospital, University of Toronto, Ontario, Canada
                Article
                10.1177/0896860821989874
                33882725
                4e00470c-28b8-4fba-a41d-7835afd741e7
                © 2022

                https://creativecommons.org/licenses/by/4.0/

                History

                Comments

                Comment on this article